The largest database of trusted experimental protocols

21 protocols using synapt g2 si q tof

1

Spectral and Mass Spectrometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
J o u r n a l P r e -p r o o f were performed in a spectral region between 4,000 and 450 cm -1 and analyzed by absorbance at a resolution of 4 cm -1 after 8 scans. HRMS analyses were carried out on a Q-TOF Synapt G2-Si (Waters Corp., Milford, MA, USA) spectrometer. All spectra and chromatograms can be found in the Supporting Information, along with the analytical characterization of the reference compound I.
+ Open protocol
+ Expand
2

Proteomics Analysis via nanoACQUITY UPLC-QTOF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteomics analysis was performed using a nanoACQUITY ultraperformance liquid chromatograph (UPLC) coupled to a Q-TOF SYNAPT G2-Si instrument (Waters, Manchester, UK) with the parameters described by Botini et al. (2021) (link). Briefly, the runs consisted of five biological replicates; in each run, 1 μg of the digested proteins were loaded onto a nanoACQUITY UPLC M-Class Symmetry C18 5 μm trap column (180 μm × 20 mm) at 5 μL min -1 for 3 min and then onto a nanoACQUITY M-Class HSS T3 1.8 μm analytical reversed-phase column (75 μm × 150 mm) at 400 nL min -1 . The column temperature was set to 45 °C. For peptide elution, a binary gradient was used, and mobile phases A and B consisted of water (Tedia, Fairfield, USA) and 0.1% formic acid and acetonitrile (Sigma-Aldrich) and 0.1% formic acid, respectively. Mass spectrometry was performed in the positive and resolution mode (V mode) with ion mobility (HDMS E ) and in the data-independent acquisition (DIA) mode.
+ Open protocol
+ Expand
3

Semi-Quantitative N-Glycan Analysis in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
From 8 patients (patients 1-3, 5-7 and 9-10) samples were collected before and after the galactose trial for semi-quantitative N-glycan mass spectrometry analysis (ESI-QTOF) 12 (link).
Briefly, heparinized plasma was combined with an internal control (sialylglycopeptide) and digested in buffered RapiGest SFTM solution. N-glycans were cleaved with PNGase FTM, reacted with RapiFluor-MS, and isolated on a HILIC column. Mass spectrometric analysis was performed on the Waters’ Synapt G2 Si QTOF as previously described.
Normal values were derived from a previously obtained cohort of 31 healthy controls.
All samples were analyzed at the Children’s Hospital of Philadelphia, Philadelphia, USA.
+ Open protocol
+ Expand
4

UPLC-PDA-HR-MS Analysis of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The UPLC-PDA-HR-MS analyses were performed on an Acquity UPLC I Class (Waters, Milford, MA, USA). The column was an Acquity UPLC HSS T3 (100 × 2.1 mm, 1.8 μm) fitted with a VanGuard cartridge (Waters). The column temperature was 30 °C and the eluents were: A, water + 0.1% formic acid and B, acetonitrile + 0.1% formic acid. Isocratic separation: 10% of eluent B at 0.350 mL/min. Injection volume: 2 µL of 250 μM solution. The detector was an Acquity UPLC PDA Detector and the wavelength selected for the analysis was 254 nm. A Synapt G2-Si QTof (Waters) High Resolution mass spectrometer equipped with a Zspray ESI-probe was used in ESI negative ionization mode. Optimized source parameters: capillary −2.0 kV, cone 40, source temperature 120 °C, desolvatation temperature 150 °C, desolvatation gas flow rate 600 L/h, and full scan range 50–800 m/z. The lock mass compound was leucine enkephalin. The software was MassLynxTM v4.2 software (Waters).
NMR spectra were performed using an Avance NEO 400 spectrometer (Bruker, Billerica, MA, USA) equipped with a “BBI 400 MHz S1” probe with Z gradient.
+ Open protocol
+ Expand
5

Quantification of Lipid Mediators by LCMS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipid mediators were examined by LCMS essentially as described previously (Quehenberger et al., 2011 (link); Tam et al., 2013 (link); Tam et al., 2020 (link)). Before lipid metabolite isolation by solid phase extraction (SPE), deuterated standards (Cayman Chemical) were added to 0.9 mL of BAL Methanol was evaporates and the samples reconstituted in a minimal volume of water/acetonitrile (60/40) containing 0.02% v/v acetic acid. Eicosanoids were separated using a Waters Acquity UPLC BEH 1.7 μm 2.1 × 50 mm column using a 4 minute gradient of 99.9% A/B to 75/25 A/B followed by washing and reconditioning. Solvent A is 50/50 water/acetonitrile containing 0.02% acetic acid and solvent B is 50/50 acetonitrile/isopropanol. Eicosanoids were analyzed by a Waters Synapt G2Si QTOF operated in negative-ionization mode via MSe. Data analysis was performed using UNIFI 1.6 (Waters), MS-DIAL4 (Tsugawa et al., 2020 (link)), and Mzmine 2.53 (Pluskal et al., 2010 (link)).
+ Open protocol
+ Expand
6

Virus HA Protein Structural Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were thawed for 5 min on ice and manually injected into a Waters HDX Manager kept at 1°C. Whole-virus HA samples were trapped on a Waters ACQUITY UPLC CSH C18 VanGuard, 130 Å, 1.7 μm, 2.1 mm by 5 mm trap column for 3 min with a flow of solvent A (2% acetonitrile, 0.1% FA, and 0.025% trifluoroacetic acid) at a rate of 150 μl/min. BHA samples were digested online with immobilized pepsin for 5 min and trapped as described previously (51 (link)). Peptides were resolved over a Waters ACQUITY UPLC CSH C18, 130 Å, 1.7 μm, 1 mm by 100 mm column using a 10-min linear gradient of 3 to 50% solvent B (solvent B: 100% acetonitrile and 0.1% FA) and analyzed using a Waters Synapt G2-Si Q-TOF with ion mobility enabled. Source and desolvation temperatures were 70° and 130°C, respectively. The StepWave ion guide settings were tuned to prevent nonuniform gas-phase proton exchange in the source (52 (link)). A series of trap column wash steps were implemented between each injection to minimize carryover (53 (link)).
+ Open protocol
+ Expand
7

N-Glycan Analysis by QTOF-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mass spectrometric analysis was performed on the Waters’ Synapt G2 Si QTOF in positive ion mode. Then, 2 μL of the N-glycan sample was delivered to the electrospray ionization (ESI) source through direct flow injection. Mobile phase A was 50 mmol/L ammonium formate, pH 4.4, and mobile phase B was 100% acetonitrile. Flow rate of 25% A and 75% B was set at 0.2 mL/min. Source temperature was 120 °C, and the desolvation temperature was 350 °C, with gas flow of 800 L/h. Cone and capillary voltage was 45 V and 3.0 kV, respectively. Data were acquired in resolution mode. Mass scan range was between 300 and 2000 m/z. Lockspray was used for mass calibration with 100 fmol/μL [Glu1]-fibrinopeptide B in 50% acetonitrile, 0.1% formic acid. The resolution used for this analysis was around 20000 full width at half maximum.
+ Open protocol
+ Expand
8

N-Glycan Analysis Using RapiFluor-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
RapiFluor-MS™ N-Glycan Kit and HILIC 96-well μElution™ plates were purchased from Waters. [13C]-sialylglycopeptide with >98% purity was purchased from Omicron Biochemicals. Ammonium formate, acetonitrile, water, human [Glu1]-fibrinopeptide B, and transferrin were purchased from Sigma Aldrich. Mass spectrometric analysis was performed on a Synapt G2 Si™ QTOF (Waters).
+ Open protocol
+ Expand
9

LESA CID MS/MS Protocol for Lipid Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
LESA CID MS/MS was carried out using a SYNAPT G2-Si QToF (Waters) and the LESA Advion TriVersa NanoMate was used as the ionization source60 (link). A surface extraction solvent of 95:5 methanol:water was used for all experiments. LESA parameters used for analysis were: solvent volume 4 µl, solvent depth 1 mm up from the bottom of the reservoir, dispensed 2 µl, delayed 2 s after dispensing, aspirated 3.5 µl, repeated mix two times, delayed 2 s after aspirate. Negative ion nano-ESI was used for the MS/MS analysis with spraying parameters of 0.3 psi gas pressure and 1.4 kV for applied voltage. The SYNAPT G2-Si was operated in negative ion MS/MS mode for precursor ion at m/z 464. A range of collision energies were used with the data averaged.
+ Open protocol
+ Expand
10

Metabolite Analysis by UPLC-IMS-QTOF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Metabolite analysis was achieved using a Waters ACQUITY UPLCTM I-Class chromatography system (Waters Corp, Milford, MA, USA) equipped with ion mobility mass spectrometry detector. The separation was performed on a Thermo Scientific™ Syncronis™ C18 (100 mm×2.1 mm, 1.7 mum particle size, Thermo Fisher Scientific) and the injection volume was 5 μL at 25° C. A gradient elution profile was employed using mobile phase A (0.1% formic acid in acetonitrile) and mobile phase B (0.1% formic acid in water). The following gradient was utilized: 0 min, 5% A; 0.5 min, 5% A; 3 min, 40% A; 10.5 min, 95% A. The flow rate was set to 0.40 mL/min.
The mass spectrometry was carried out using a SYNAPT G2-Si Q TOF (Waters Corp, Wilmslow, UK) connected to the ACQUITY UPLC I-Class System via an ESI interface. The mass spectrometry analysis was performed in the positive mode and negative mode, with the following parameters: Capillary 1.5 kV, sample voltage 30 V, cone voltages 5 V, source temperature 120° C, desolvation temperature 500° C. desolvation gas flow rate 800 L/h, cone gas flow rate 50 L/h. The MS was set with 0.1 second of scan time to acquire in sensitivity mode. The accurate mass precursor and fragment ion data was obtained using the selected mass range of m/z 100-1200.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!